Kalydeco ranks among 12 priciest drugs in U.S.

Posted under Blog, Companies, Diagnostics, drug prices, Funding, Kalydeco, Medical Devices, Medical Supply, Pharmaceuticals, Startups, Universities, vertex, Videos by John Carroll

Last week, Vertex Pharmaceuticals ($VRTX) got FDA approval for Kalydeco, the first cystic fibrosis drug to address the disease's cause, rather than just its symptoms. The price tag: $294,000. But as observers pointed out at the time, that's not as expensive as it gets. Today's drugs for debilitating and rare diseases command 6 figures almost as a matter of course. Medical Billing & Coding's blog reminds us just how much--and shows where Kalydeco ranks. Story